These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 26807548

  • 1. Unique Use of Alkylation for Chemo-Redox Activity by a Pt(IV) Prodrug.
    Pathak RK, Dhar S.
    Chemistry; 2016 Feb 24; 22(9):3029-36. PubMed ID: 26807548
    [Abstract] [Full Text] [Related]

  • 2. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H, Cheng Q, Yuan S, Ding X, Liu Y.
    Chemistry; 2015 Nov 09; 21(46):16547-54. PubMed ID: 26405808
    [Abstract] [Full Text] [Related]

  • 3. Emerging JWA-targeted Pt(IV) prodrugs conjugated with CX-4945 to overcome chemo-immune-resistance.
    Chen F, Pei S, Wang X, Zhu Q, Gou S.
    Biochem Biophys Res Commun; 2020 Jan 15; 521(3):753-761. PubMed ID: 31703842
    [Abstract] [Full Text] [Related]

  • 4. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
    Xiao H, Yan L, Zhang Y, Qi R, Li W, Wang R, Liu S, Huang Y, Li Y, Jing X.
    Chem Commun (Camb); 2012 Nov 11; 48(87):10730-2. PubMed ID: 23012698
    [Abstract] [Full Text] [Related]

  • 5. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance.
    Li L, Huang X, Huang R, Gou S, Wang Z, Wang H.
    Eur J Med Chem; 2018 Aug 05; 156():666-679. PubMed ID: 30031977
    [Abstract] [Full Text] [Related]

  • 6. A Pt(IV) Prodrug Combining Chlorambucil and Cisplatin: a Dual-Acting Weapon for Targeting DNA in Cancer Cells.
    Montagner D, Tolan D, Andriollo E, Gandin V, Marzano C.
    Int J Mol Sci; 2018 Nov 27; 19(12):. PubMed ID: 30486477
    [Abstract] [Full Text] [Related]

  • 7. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.
    Pathak RK, Wen R, Kolishetti N, Dhar S.
    Mol Cancer Ther; 2017 Apr 27; 16(4):625-636. PubMed ID: 28148716
    [Abstract] [Full Text] [Related]

  • 8. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S, Bolanowska-Higdon W, Zdanowicz J, Hitt S, Pendyala L.
    Cancer Chemother Pharmacol; 2001 Nov 27; 48(5):398-406. PubMed ID: 11761458
    [Abstract] [Full Text] [Related]

  • 9. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR.
    Dalton Trans; 2020 Jun 23; 49(24):8107-8113. PubMed ID: 32490446
    [Abstract] [Full Text] [Related]

  • 10. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.
    Ravera M, Gabano E, Zanellato I, Bonarrigo I, Alessio M, Arnesano F, Galliani A, Natile G, Osella D.
    J Inorg Biochem; 2015 Sep 23; 150():1-8. PubMed ID: 26042542
    [Abstract] [Full Text] [Related]

  • 11. A CK2-targeted Pt(IV) prodrug to disrupt DNA damage response.
    Chen F, Huang X, Wu M, Gou S, Hu W.
    Cancer Lett; 2017 Jan 28; 385():168-178. PubMed ID: 27793693
    [Abstract] [Full Text] [Related]

  • 12. Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
    Ma R, Wang Y, Yan L, Ma L, Wang Z, Chan HC, Chiu SK, Chen X, Zhu G.
    Chem Commun (Camb); 2015 May 07; 51(37):7859-62. PubMed ID: 25854514
    [Abstract] [Full Text] [Related]

  • 13. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z, Wang H, Li Y, Qin Y, Xu L, Bowers DJ, Gangoda M, Li X, Yang HB, Zheng YR.
    Chem Commun (Camb); 2018 Jan 18; 54(7):731-734. PubMed ID: 29303526
    [Abstract] [Full Text] [Related]

  • 14. Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy.
    Tang L, Luo Y, Luo W, Sun G, Jiang Y, Zhang Z, Yue X, Li S, Liang L, Liu W, Hu J.
    Curr Protein Pept Sci; 2024 Jan 18; 25(10):797-813. PubMed ID: 38919078
    [Abstract] [Full Text] [Related]

  • 15. Alternative mechanism of action of the DNP PtIV prodrug: intracellular cisplatin release and the mitochondria-mediated apoptotic pathway.
    Krasnovskaya O, Spector D, Erofeev A, Gorelkin P, Akasov R, Skvortsov D, Trigub A, Vlasova K, Semkina A, Zyk N, Beloglazkina E, Majouga A.
    Dalton Trans; 2021 Jun 15; 50(23):7922-7927. PubMed ID: 34037020
    [Abstract] [Full Text] [Related]

  • 16. Studies on cellular accumulation of satraplatin and its major metabolite JM118 and their interactions with glutathione.
    Kostrhunova H, Kasparkova J, Gibson D, Brabec V.
    Mol Pharm; 2010 Dec 06; 7(6):2093-102. PubMed ID: 20936822
    [Abstract] [Full Text] [Related]

  • 17. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z, Wang Z, Yiu SM, Zhu G.
    Dalton Trans; 2015 Dec 14; 44(46):19918-26. PubMed ID: 26514681
    [Abstract] [Full Text] [Related]

  • 18. Platin-C containing nanoparticles: a recipe for the delivery of curcumin-cisplatin combination chemotherapeutics to mitochondria.
    Banik B, Ashokan A, Choi JH, Surnar B, Dhar S.
    Dalton Trans; 2023 Mar 21; 52(12):3575-3585. PubMed ID: 36723189
    [Abstract] [Full Text] [Related]

  • 19. Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance.
    Wang M, Li G, Jiang G, Cai J, Liu Z, Huang R, Huang X, Wang H.
    J Med Chem; 2024 Apr 25; 67(8):6218-6237. PubMed ID: 38573870
    [Abstract] [Full Text] [Related]

  • 20. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
    Johansson K, Ito M, Schophuizen CM, Mathew Thengumtharayil S, Heuser VD, Zhang J, Shimoji M, Vahter M, Ang WH, Dyson PJ, Shibata A, Shuto S, Ito Y, Abe H, Morgenstern R.
    Mol Pharm; 2011 Oct 03; 8(5):1698-708. PubMed ID: 21851097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.